Health · 1 sources covering this

STAT+: AstraZeneca opens new Boston site

AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: AstraZeneca opens new Boston site
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/f568afc6f0cc4efdb8e57d563976973b8ba846c2"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: AstraZeneca opens new Boston site"></iframe>

STAT+: AstraZeneca opens new Boston site

How 1 sources are covering this

STAT+: AstraZeneca opens new Boston site

More from Health

STAT+: Are stem cell treatments about to have their day?

What are hospital longevity programs, and what can they tell you about your health?

STAT+: FDA spells out 2027 AI guidance plans

STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: AstraZeneca opens new Boston site

More from Health

STAT+: Are stem cell treatments about to have their day?

What are hospital longevity programs, and what can they tell you about your health?

STAT+: FDA spells out 2027 AI guidance plans

STAT+: Pharmalittle: We&#8217;re reading about U.S.-funded psychedelic trials, an AstraZeneca R&#038;D center, and more

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more